Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 61 articles: HTML format

Single Articles

July 2024
1. FAKIH MG, Chao J
   Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.
   N Engl J Med. 2024;391:187.
   PubMed    
   
   
   
2. FOJO T
   Sotorasib in KRAS-Mutated Colorectal Cancer.
   N Engl J Med. 2024;391:186-187.
   PubMed    
   
   
   June 2024
3. IMPERIALE TF, Porter K, Limburg PJ
   Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
   N Engl J Med. 2024;390:2225.
   PubMed    
   
   
   
4. CHUNG DC, Raymond VM, Grady WM
   Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
   N Engl J Med. 2024;390:2224-2225.
   PubMed    
   
   
   
5. MANNUCCI A, Goel A
   Stool and Blood DNA Tests for Colorectal Cancer Screening.
   N Engl J Med. 2024;390:2224.
   PubMed    
   
   
   
6. SAFARI F, Noursina A, Rouzbahani S
   Stool and Blood DNA Tests for Colorectal Cancer Screening.
   N Engl J Med. 2024;390:2223-2224.
   PubMed    
   
   
   
7. MATUCHANSKY C
   Stool and Blood DNA Tests for Colorectal Cancer Screening.
   N Engl J Med. 2024;390:2222-2223.
   PubMed    
   
   
   
8. CERCEK A
   Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?
   N Engl J Med. 2024;390:2024-2025.
   PubMed    
   
   
   
9. CHALABI M, Verschoor YL, Tan PB, Balduzzi S, et al
   Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.
   N Engl J Med. 2024;390:1949-1958.
   PubMed     Abstract available
   
   
   April 2024
10. MARIN-ESTEBAN V, Molet L, Lagana M, Ciocan D, et al
    CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
    N Engl J Med. 2024;390:1339-1341.
    PubMed    
    
    
    March 2024
11. LO YMD
    Cell-free DNA for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1047-1050.
    PubMed    
    
    
    
12. CARETHERS JM
    Improving Noninvasive Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1045-1046.
    PubMed    
    
    
    
13. IMPERIALE TF, Porter K, Zella J, Gagrat ZD, et al
    Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:984-993.
    PubMed     Abstract available
    
    
    
14. CHUNG DC, Gray DM 2nd, Singh H, Issaka RB, et al
    A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:973-983.
    PubMed     Abstract available
    
    
    December 2023
15. YAEGER R
    Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal Cancer.
    N Engl J Med. 2023;389:2197-2199.
    PubMed    
    
    
    October 2023
16. SCHRAG D
    Preoperative Treatment of Locally Advanced Rectal Cancer. Reply.
    N Engl J Med. 2023;389:1631-1632.
    PubMed    
    
    
    
17. SEBAG-MONTEFIORE D, Cervantes A, Rodel C
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1631.
    PubMed    
    
    
    
18. SHAH N
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1630-1631.
    PubMed    
    
    
    
19. FAKIH MG, Salvatore L, Esaki T, Modest DP, et al
    Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2023 Oct 22. doi: 10.1056/NEJMoa2308795.
    PubMed     Abstract available
    
    
    August 2023
20. SACHER A, LoRusso P, Patel MR, Miller WH Jr, et al
    Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
    N Engl J Med. 2023;389:710-721.
    PubMed     Abstract available
    
    
    July 2023
21. DOSSA F, Baxter NN
    Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:375-377.
    PubMed    
    
    
    
22. SCHRAG D, Shi Q, Weiser MR, Gollub MJ, et al
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:322-334.
    PubMed     Abstract available
    
    
    
23. TABERNERO J, Fakih M, Prager GW
    Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
    N Engl J Med. 2023;389:190-191.
    PubMed    
    
    
    
24. VAN DE HAAR J, Valeri N, Voest EE
    Third-Line Therapy in Metastatic Colorectal Cancer.
    N Engl J Med. 2023;389:190.
    PubMed    
    
    
    May 2023
25. YEKU OO, Longo DL
    Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer.
    N Engl J Med. 2023;388:1711-1714.
    PubMed    
    
    
    
26. PRAGER GW, Taieb J, Fakih M, Ciardiello F, et al
    Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
    N Engl J Med. 2023;388:1657-1667.
    PubMed     Abstract available
    
    
    March 2023
27. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    PubMed     Abstract available
    
    
    January 2023
28. DOMINITZ JA, Robertson DJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:379.
    PubMed    
    
    
    
29. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    PubMed    
    
    
    
30. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    PubMed    
    
    
    
31. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    PubMed    
    
    
    
32. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    PubMed    
    
    
    
33. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    PubMed    
    
    
    
34. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    PubMed    
    
    
    December 2022
35. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    PubMed     Abstract available
    
    
    November 2022
36. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    PubMed    
    
    
    October 2022
37. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    PubMed    
    
    
    
38. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed     Abstract available
    
    
    September 2022
39. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    PubMed    
    
    
    
40. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    PubMed    
    
    
    
41. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    PubMed    
    
    
    August 2022
42. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    PubMed    
    
    
    
43. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    PubMed    
    
    
    
44. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    PubMed    
    
    
    
45. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    PubMed    
    
    
    
46. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    PubMed    
    
    
    
47. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    PubMed    
    
    
    
48. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    PubMed    
    
    
    July 2022
49. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed    
    
    
    
50. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed    
    
    
    
51. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed    
    
    
    June 2022
52. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    PubMed    
    
    
    
53. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    PubMed     Abstract available
    
    
    
54. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available
    
    
    
55. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    PubMed    
    
    
    
56. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed     Abstract available
    
    
    
57. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    PubMed    
    
    
    April 2022
58. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    PubMed    
    
    
    February 2022
59. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    PubMed    
    
    
    
60. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    
    
    
    January 2022
61. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.